[fr] Récemment, les anticorps anti-gliadines déamidées ont supplanté les
anti-gliadines natives dans le diagnostic sérologique des patients coeliaques.
Cette étude a pour but d’évaluer la spécificité des frousses utilisant des peptides de gliadine déamidée et de la comparer à celle des tests basés sur la gliadine native. Les anticorps anti-gliadines natives, anti-gliadines déamidées et anti-transglutammase neo-epitope ont ete doses par cmq differentes techniques Elisa (IgA et IgG) quantitatives, ainsi que par un Eisa de screemng chez 46 patients non coeliaques. Les anticorps anti-gliadines natives IgA et 1gO sont trouvés chez 24 et 63 % des patients non coeliaques, respectivement. L’utilisation de la gliadine déamidée réduit le nombre de résultats faussement positifs en IgA et particulièrement en 1gO: 21 et 24 % respectivement des patients pour la frousse Anti-Gliadin (GAF-3X) Euroinunun, 7 et 26 % pour la frousse Bindazyme Euman Anti-Gliadin (MGP) fle Binding Site ainsi que O et 41 % pour la frousse Celiac G+ Immco. La trousse anti-transglutaminase néo-épitope, recherchant simultanément les anticorps anti-transglutaniinase, anti-gliadines déamidées et anti-néo-épitope, n’apporte pas une réelle aide au diagnostic différentiel de la maladie coeliaque car 30 % des patients présentent un résultat positif en 1gO contre 2 % en IgA. La frousse de screening d’Inova, recherchant simultanément les anticorps anti-transglutaniiuase et anti-gliadines déamidées, présente une positivité chez 24 % de la cohorte. En conclusion, le dosage des anticorps anti-gliadines déamidées paraît être la méthode de choix pour sa plus grande spécificité face aux anticorps anti-gliadines natives dans le diagnostic différentiel de la maladie coeliaque. [en] Recently, anti-deamidated gliadin antihodies were proposed for the serological diagnosis of celiac disease. We evaluate the specificity of different anti-deamidated gliadin antibodies ELISA in comparison with conventional anti-native gliadin kits. Serum sainples froin 46 non celiac patients trere analyzed by five different quantitative ELISA for anti-native gliadin, antideamidated gliadin and anti-fransglutaininase neo-epitope antibodies together with a screening ELISA. Twenty-four percent of the patients deinonstrated anti-native gliadin lgA and 63% 1gO antibodies. Using anti-dearnidated gliadin antibodies, tire number of false positive IgA and, particularly, 1gG results,markedly decreased in the non celiac patients: 21 and 24% respectively with anti-Gliadin (GAF-3X) Euroimmun kit, 7 and 26% with Bindazyme 1-lurnan Anti-Gliadin (MGP) The Binding Site kit and 0 and 41% with Celiac G+ Immco kit. The new assay which makes use of the physiological complex of tissue transglutaminase cross-linked with deamidated gliadin peptides, called neo-epitope, did not improve the differential diagnosis of celiac disease with 30% of false positive results in IgG (2% in IgA). IJsing the Inova screening kit, a positive resuit for IgA and/or IgG anti-deamidated gliadin and!or anti- tissue transglutaminase antibodies was obtained in 24% of the non celiac patients. In conclusion, our study assessed the superiority, in ternis of specificity, of anti-deamidated gliadin antibodies, over the conventional anti-gliadin antibodies for die differential diagnosis of celiac disease.
Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357:1731-43.
Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer. J Exp Med 1989;169:345-50.
van Heel DA, West J. Recent advances in coeliac disease. Gut 2006;55:1037-46.
Dewar D, Pereira SP, Ciclitira PJ. The pathogenesis of coeliac disease. Int J Biochem Cell Biol 2004;36:17-24.
Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990;65:909-11.
Chorzelski TP, Sulej J, Tchorzewska H, Jablonska S, Beutner EH, Kumar V. IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann NY Acad Sci 1983;420:325-34.
Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797-801.
Carroccio A, Vitale G, Di Prima L, Chifari N, Napoli S, La Russa C, et al. Comparison of anti-transglutaminase ELISA and an antiendomysial antibody assay in the diagnosis of celiac disease : a prospective study. Clin Chem 2002;48:1546-50.
Unsworth DJ, Manuel PD, Walker-Smith JA, Campbell CA, Johnson GD, Holborow EJ. New immunofluorescent blood test for gluten sensitivity. Arch Dis Child 1981;56:864-8.
Aleanzi M, Demonte AM, Esper C, Garcialazo S, Waggener M. Celiac disease : antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 2001;47:2023-8.
Schwertz E, Kahlenberg F, Sack U, Richter T, Stern M, Conrad K, et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin Chem 2004;50:2370-5.
Skovbjerg H, Koch C, Anthonsen D, Sjöström H. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease. Biochim Biophys Acta 2004;1690:220-30.
Fleckenstein B, Qiao SW, Larsen MR, Jung G, Roepstorff P, Sollid LM. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J Biol Chem 2004;279:17607-16.
Volta U, Granito A, Fiorini E, Parisi C, Piscaglia M, Pappas G, et al. Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci 2008;53:1582-8.
Prince HE. Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides. Clin Vaccine Immunol 2006;13:150-1.
Reeves GE, Squance ML, Duggan AE, Murugasu RR, Wilson RJ, Wong RC, et al. Diagnostic accuracy of coeliac serological tests : a prospective study. Eur J Gastroenterol Hepatol 2006;18:493-501.
Rashtak S, Ettore MW, Homburger HA, Murray JA. Combination testing for antibodies in the diagnosis of coeliac disease : comparison of multiplex immunoassay and ELISA methods. Aliment Pharmacol Ther 2008;28:805-13.
Villalta D, Alessio MG, Tampoia M, Tonutti E, Brusca I, Bagnasco M, et al. Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency. A comparison of the diagnostic accuracy of 9 IgG anti-tissue transglutaminase, 1 IgG anti-gliadin and 1 IgG anti-deaminated gliadin peptide antibody assays. Clin Chim Acta 2007;382:95-9.